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Axillary lymph nodes in breast cancer patients: sonographic
evaluation*
Linfonodos axilares em pacientes com câncer de mama: avaliação ultrassonográfica
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Abstract
Resumo
Axillary staging of patients with early-stage breast cancer is essential in the treatment planning. Currently such staging is intraoperatively
performed, but there is a tendency to seek a preoperative and less invasive technique to detect lymph node metastasis. Ultrasonography
is widely utilized for this purpose, many times in association with fine-needle aspiration biopsy or core needle biopsy. However, the sonographic
criteria for determining malignancy in axillary lymph nodes do not present significant predictive values, producing discrepant results in
studies evaluating the sensitivity and specificity of this method. The present study was aimed at reviewing the literature approaching the
utilization of ultrasonography in the axillary staging as well as the main morphological features of metastatic lymph nodes.
Keywords: Breast cancer; Axillary lymph nodes; Axillary ultrasonography; Morphological features.
O estadiamento axilar nas pacientes portadoras de câncer de mama inicial é fator essencial no planejamento terapêutico. Atualmente
este é realizado durante o tratamento cirúrgico, mas há uma tendência em buscar técnicas pré-operatórias e de menor morbidade para
avaliação dos linfonodos axilares. A ultrassonografia é um exame amplamente usado para esta finalidade e muitas vezes associado a
punção aspirativa por agulha fina ou por agulha grossa. Entretanto, os critérios ultrassonográficos de suspeição para linfonodos axilares
não apresentam valores preditivos significativos, gerando resultados discrepantes em estudos sobre sensibilidade e especificidade do
método. O objetivo deste trabalho é realizar uma revisão na literatura médica sobre a ultrassonografia no estadiamento axilar e as
principais alterações morfológicas do linfonodo metastático.
Unitermos: Câncer de mama; Linfonodos axilares; Ultrassonografia; Aspectos morfológicos.
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negative axilla, currently obtaining less than 1% of axillary
recurrence in patients with negative SLNB(2). In the meta-
analysis by Kell et al., SLNB demonstrated to be equivalent
to axillary dissection in the detection of metastasis in regional
lymph nodes and with up to 75% less morbidity in patients
with early stage disease(3).
According to studies in the literature, axillary dissec-
tion followed by positive results for metastasis at SLNB pre-
sented 38% to 67% of metastasis absence in the remaining
lymph nodes(4). Such data raised the question of what is the
actual benefit of wide lymph node dissection in cases where
the sentinel lymph node is compromised. Such benefit is
particularly unknown in the cases of micrometastasis and
isolated tumor cells in which clinical meaning is still unde-
termined. The studies on the subject are still controversial,
and currently most services adopt the wide axillary approach,
even in those cases where the sentinel lymph node is mini-
mally compromised(5). The identification of new prognos-
tic markers, the better understanding of tumors behavior
and the technological developments in imaging methods
have a great potential of bringing changes in axillary stag-
ing in the future, by selecting patients eligible to less ag-
gressive interventions. Recently the ACOSOG Z0011 study
defined the profile of a group of patients eligible to non-
axillary chain dissection after positive SLNB(6). Such a pro-
tocol is followed by the Division of Mastology at Escola
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INTRODUCTION
The presence or absence of metastatic disease in the re-
gional lymph node chain is crucial information for the defi-
nition of staging, treatment and prognosis of breast cancer.
Axillary lymphadenectomy in association with histological
analysis is still the gold standard in the evaluation of such
lymph nodes; but this method is associated with relevant
morbidity. With the advances in breast imaging diagnosis
and consequential increased incidence of cases of early stage
disease, the presence of axillary lymph nodes metastasis has
declined, and a less aggressive option became necessary.
The technique of sentinel lymph node biopsy (SLNB)
initially introduced by Krag in 1993(1), represented a rel-
evant advance in the treatment of patients with clinically
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Paulista de Medicina – Universidade Federal de São Paulo
since November, 2012.
Both clinical examination and mammography demon-
strably do not present appropriate accuracy in the identifi-
cation of axillary lymph nodes metastasis(7) and several stud-
ies approach other imaging techniques, such as: ultrasonog-
raphy alone or in association with Doppler flowmetry; fine
needle aspiration biopsy (FNAB) or core biopsy; computed
tomography; positron emission tomography; magnetic reso-
nance imaging; elastography.
Currently, no imaging method has enough negative pre-
dictive value to avoid a surgical approach to the axilla in cases
where no lymph node involvement is identified(8), however
an increasing number of studies include such methods as part
of the therapeutic planning. A study is currently being un-
dertaken at the European Oncology Institute, comparing
SLNB versus observation alone when axillary ultrasonogra-
phy is negative in patients with small breast cancer candi-
dates to breast conserving surgery (9).
Axillary ultrasonography plays a relevant role in the stag-
ing and follow-up of regional lymph nodes. It is an easily
accessible noninvasive method which is helpful in obtaining
material for cytology and histology.
The present study was aimed at discussing the utiliza-
tion of ultrasonography in axillary staging, with emphasis
on the main morphological changes of metastatic lymph
nodes observed at such method.
METHOD
The adopted method was the systematic bibliographi-
cal research for the production of a review article to meet
the proposed objective. An active search for articles on the
proposed theme was undertaken at a scientific browser (Google
scholar), websites (Faculdade de Medicina da Universidade
de São Paulo and Conselho Federal de Medicina), virtual
reference databanks (Medline, Lilacs, Cochrane, SciELO,
High Wire, Ovid), utilizing the following keywords: “linfo-
nodos axilares” (axillary lymph nodes), “ultrassonografia”
(ultrasonography), “aspectos morfológicos” (morphological
features). The search was carried out in the period of Janu-
ary through August of 2012. In the present article, 22 refer-
ences which best covered the proposed theme were utilized.
REVIEW
Ultrasonography is widely available and, as combined with
FNAP or core biopsy, it is the most significant method for
preoperative evaluation of axillary lymph nodes(10). In the
presence of a negative cytological or histological result for
axillary metastasis, the negative predictive value of SLNB is
increased; on the other hand, in the presence of a positive result,
the surgical time is shortened by not performing biopsy.
Another benefit from such method would be the reduc-
tion in the occurrence of inappropriate lymphatic mapping
by previously identifying, by means of ultrasonography,
lymph nodes with tumor cell deposits increasing the lym-
phatic pressure, thus reducing the radioactive colloid up-
take(11).
A previously mentioned, a positive sentinel lymph node,
in many cases, is the only affected lymph node, and biopsy
would not be an appropriate method to evaluate the axillary
involvement extent in such a case(2,6). On the other hand,
the utilization of ultrasonography in association with FNAP,
in the study developed by Moore et al., has demonstrated
high probability of extensive axillary involvement (more than
four lymph nodes) in the presence of morphological changes
such as absence of hilum and/or extracapsular extension and
cytological confirmation of malignancy(12).
In spite of presenting a high accuracy in many studies,
the diagnostic criteria for malignancy and the indication of
the method remain controversial(4).
MORPHOLOGICAL CHARACTERISTICS
Usually, a benign lymph node is ovoid, with a hypo-
echogenic cortex, extremely thin or even invisible at ultra-
sonography with a hyperechogenic hilum due to connective
tissue trabeculae, lymphatic tissue cords and medullary si-
nusoids. Changes such as cortical thickening, hilum decrease
or absence, changes in shape or vascular pattern, are con-
sidered suspicious.
Currently many studies utilize cortical thickening and
hilum absence as criteria for definition of the risk for me-
tastasis(11,12–16). Absence of the hilum, making the lymph
node completely hypoechogenic, is the most specific alter-
ation for metastatic disease(13,16), but such finding is present
only in cases of advanced disease. The great challenge in
sonographic diagnosis lies in the evaluation of lymph nodes
whose cortex and hilum are observed in varied forms, corre-
sponding to early stages of metastatic disease, with such cases
being responsible for the largest proportion of false-nega-
tive cases(11–13,16).
Metastatic cells in the lymph reach the lymph nodes
through afferent lymphatic vessels on the convex aspect of
the organ. Then, the lymph is filtered through the cortex,
paracortex and finally the hilum(17). Metastatic deposits ac-
cumulate in the lymph node peripheral area, causing enlarge-
ment of the cortex, usually focal (at early stages), or uni-
form. Minimum lymph node involvement, with deposits
between 0.2 and 2 mm (micrometastasis), and < 0.2 mm
(isolated tumor cells) is not related to significant morpho-
logical changes in the lymph node, thus limiting the useful-
ness of ultrasonography in such cases, so the diagnosis is made
by means of histology or immunohistochemistry.
With the objective of estimating the suspicion based on
image, many authors have developed classifications based
on the cortical thickness. Cho et al.(11), for example, have
categorized the images into five grades: grade 1, lymph nodes
with cortex ≤ 1.5 mm; grade 2, > 1.5 and ≤ 2.5 mm; grade
3, > 2.5 mm and ≤ 3.5 mm; grade 4, > 3.5 mm and intact
hilum; grade 5, > 3.5 mm and hilum absence. Such authors
have concluded that such classification is effective in the
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investigation of metastasis, and that cortical thickness > 2.5
mm is an indication for cytological or histological study.
Bedi et al.(13) have created a similar classification, di-
viding the images into six types, as follows: type 1, without
visible cortex; type 2, cortex ≤ 3 mm; type 3, cortex > 3
mm; type 4, entirely lobulated cortex; type 5, with focal lobu-
lation; type 6, completely hypoechogenic, without hilum.
Lymph nodes classified as types 5 and 6 were considered sus-
picious, with indication for biopsy; reactional changes were
frequently observed in type 3; while type 4 was considered
as probably benign, since such type comprised most false-
negative results (Figures 1 to 7).
Figure 1. Bedi type 1 lymph node. Without visible cortex. (H, hilum).
Figure 2. Bedi type 2 lymph node. Uniform cortex = 3 mm. (H, hilum).
Figure 3. Bedi type 3 lymph node. Uniform cortex > 3 mm cortex. (H, hilum).
Figure 4. Bedi type 4 lymph node. Entirely lobulated cortex. (H, Hilum).
Figure 7. Bedi type 6 lymph node at ultrasonography. Lymph node without an
apparent hilum.
Figure 5. Bedi type 5 lymph node. Cortex with focal lobulation. (H, hilum; T,
tumor cell deposit).
Figure 6. Bedi type 6 lymph node. Completely hypoechogenic lymph node, ab-
sent hilum (T, tumor cell deposit).
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Mainiero et al(14). have adopted 3 mm as the cut-off point
for cortical thickness, besides the presence or not of lobula-
tion and absence of the hilum. On the other hand, Deurloo
et al.(18) have utilized 2.3 mm as a predictive factor of me-
tastasis.
One observes that value for cortical thickness utilized
as a cut-off point for metastatic disease varies a lot in the
literature, as well as sensitivity and specificity of the method
as a function of the selected value. Thus, some authors opted
for utilizing a cortex/hilum ratio, instead of an absolute value
for the cortex; in such an instance, the cortical thickening is
present when the maximum cortex thickness is ≥ the thick-
ness of the fatty hilum(16,19) (Figures 8 to 10).
As regards other morphological changes, the change in
the lymph node shape generally occurs in advanced cases,
in association with hilum absence. Size used to be consid-
ered a relevant criterion, but recent studies have not demon-
strated a significant relationship between size and malig-
nancy(13,20). Moore et al.(12) have observed that the combi-
nation of normal and changed lymph nodes in a single study
could be an important criterion, and in their study, lymph
nodes with cortical thickening not associated with normal
lymph nodes corresponded to false-positive cases.
The vascularization studied at Doppler ultrasonography,
basically follows two patterns, namely the central pattern, with
a single hilum vascular signal or dispersed signals distrib-
uted at the center of the organ, and the peripheral pattern,
where a linear signal is observed along the peripheral zone
of the organ. Peripheral vascularization is more frequently
found in metastatic lymph nodes, while the central pattern
is more frequently found in the absence of malignancy. The
indices of resistance, pulsatility and peak systolic velocity
do not differentiate between malignant and benign axillary
lymph nodes, but the relevance of such data has already been
demonstrated in studies on cervical lymph nodes(15). The
importance of the utilization of Doppler as a diagnostic cri-
teria is observed as it is associated with other morphologi-
cal characteristics and not as an isolated criteria(15,16).
INDICATION OF THE METHOD AND SELECTION
OF THE PROCEDURE (FNAP × CORE BIOPSY)
The indiscriminate utilization of ultrasonography fol-
lowed by FNAP or core biopsy has demonstrated to be hardly
practical and expensive(12,18). The largest the primary breast
tumor is, the highest is the chance of axillary metastasis, so
the indication for the procedure is clear in these cases. How-
ever, the indication in those cases of primary tumors < 2 cm
(T1) is not yet established. Mainiero et al.(14) have reduced
sentinel lymph node biopsies by 6% by indicating ultrasonog-
raphy and FNAP for patients with tumors < 1 cm. Such
number increased to 17% in those cases of primary tumors
between 1 and 2 cm, and to 42% in the cases of tumors
measuring between 2 and 5 cm.
Once an abnormal lymph node is found, one faces the
question on which procedure would be more appropriate:
FNAP or core biopsy. Such a decision should be made tak-
ing into account various peculiar aspects of each method.
FNAP is fast, with high sensitivity and specificity, besides
being less invasive; on the other hand, it requires an experi-
enced cytologist, a professional who is only available at a
small number of institutions.
Core biopsy, albeit more expensive, provides material
for histological and immunohistochemical analysis and has
a higher sensitivity as compared with FNAP(21). However, a
negative result by means of such a method does not exclude
SLNB, as the core biopsy, as well as FNAB, presents a per-
Figure 8. Representation of a cortex with a normal thickness. Measure of the
fatty hilum greater than the cortex thickness.
Figure 9. Cortical thickening representation. Cortical thickness = fatty hilum
thickness.
Figure 10. Lymph node with cortical thickening at ultrasonography. Maximum
cortical thickness (2) > hilum thickness (1).
Pinheiro DJPC et al. / Axillary lymph nodes – sonographic evaluation
Radiol Bras. 2014 Jul/Ago;47(4):240–244244
centage of false-negatives as a function of small metastatic
deposits(16). It is important to highlight that although core
biopsy presents a higher potential for complications such as
bleeding and nerve injury, it has demonstrated to be very safe
with a technique described by Abe et al., where the cannula
only crosses the tissue already limited by the needle(22).
CONCLUSION
Ultrasonography represents an important resource in the
preoperative evaluation of axillary lymph nodes in patients
with breast cancer. The utilization of this method allows for
the identification of the axillary disease extent and assists in
percutaneous biopsy, but it presents a limited benefit in those
cases with minimum lymph node involvement, such as in
those cases of micrometastasis and isolated tumor cells.
Changes such as cortical thickening and hilum absence
are predictors of metastatic disease, and cytological or his-
tological analysis is indicated in cases where such changes
are present.
Axillary ultrasonography and elective puncture/biopsy
should be a part of breast cancer diagnosis routine, particu-
larly in those cases of primary tumors > 1 cm, which are the
ones that benefit the most from this method.
The choice between FNAP and core biopsy should be
made according to the equipment and professionals avail-
able at the institution.
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